Systemic Sclerosis: Clinical Trials

3 trials for Systemic Sclerosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 unknown. 3 Phase 3, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 33Unknown 3
Phase 22Unknown 2

Follow Systemic Sclerosis: new trials by email Literature Review of Systemic Sclerosis trials Research Report on Systemic Sclerosis

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
COvid-19 Vaccine Booster in Immunocompromised Rheumatic Diseases
COVID-19 vaccine - Rheumatoid Arthritis, Autoimmune Rheumatologic Disease
Phase 2 / Phase 3UnknownPaul R Fortin2872022-03-092023-01-17
Pirfenidone as Treatment of Skin Fibrosis in Systemic Sclerosis
Pirfenidone, Placebo oral capsule, Steroids - Systemic Sclerosis
Phase 2 / Phase 3UnknownRenJi Hospital722017-05-012017-03-01
Effects of Probiotics on Gastrointestinal Symptoms and on the Immune System in Patients With Systemic Sclerosis
Probiotic, Placebo - Systemic Sclerosis, Scleroderma
Phase 3UnknownFederal University of São Paulo762014-12-012014-11-27

Narrower conditions

Scleroderma, Systemic (3)  ·  Scleroderma, Diffuse (2)  ·  Arthritis, Rheumatoid (1)  ·  Lupus Erythematosus, Systemic (1)  ·  MASS syndrome (1)  ·  Systemic Vasculitis (1)  ·  Undifferentiated Connective Tissue Diseases (1)

Broader conditions

Connective Tissue Diseases (3)  ·  Skin Diseases (3)  ·  Skin and Connective Tissue Diseases (3)  ·  Arthritis (1)  ·  Autoimmune Diseases (1)  ·  Cardiovascular Diseases (1)  ·  Immune System Diseases (1)  ·  Joint Diseases (1)  ·  Musculoskeletal Diseases (1)  ·  Rheumatic Diseases (1)  ·  Vascular Diseases (1)  ·  Vasculitis (1)

Interventions

COVID-19 Vaccines (1)  ·  Probiotics (1)  ·  Steroids (1)  ·  pirfenidone (1)

Sponsors

Federal University of São Paulo (1)  ·  Paul R Fortin (1)  ·  RenJi Hospital (1)

Countries

Brazil (1)  ·  Canada (1)  ·  China (1)

Top investigators

Cristiane Kayser (1)  ·  Paul R Fortin, MD,MPH,FRCPC (1)

Results publications

PMID 31056685